Comunicados à imprensa

dsm-firmenich advances skin microbiome science with landmark publication on leading-edge beauty science.

Our world-leading scientists have developed a novel 3D facial skin microbiome mapping technology, which unlocks new avenues for scientific discoveries and the co-creation of next-generation cosmetic innovations.

dsm-firmenich appoints TER Chemicals as exclusive distributor for Beauty & Care in Germany and the Netherlands

PARSOL® Shield Approved by FDA, dsm-firmenich Setting a New Era for U.S. Sun Protection

dsm-firmenich introduces GLYCARE® SK range: HMO biotechnology for skin regeneration and resilience

dsm‑firmenich wins bronze for ‘Best Active Ingredient’ Award at in‑cosmetics Global 2026 for EXOVIVE™ LIFT

dsm‑firmenich wins gold for ‘Best Green Ingredient’ Award at in‑cosmetics Global 2026 for ALPAFLOR® NEUROSOOTH

dsm-firmenich introduces EXOVIVE™ LIFT: The next generation science-backed exosomes, and the first in a breakthrough range of products

dsm-firmenich unveils its Dream-led Science at in-cosmetics Global 2026

dsm-firmenich introduces ALPAFLOR® NEUROSOOTH: climate-adaptive neurocosmetic science for holistic skin wellbeing

PARSOL® Shield FDA Approval Coming Soon: Ushering in a New Era of Sun care Innovation in the U.S.

PARSOL® Shield now approved for all sunscreen products by Health Canada, a new era of sun protection

dsm-firmenich and ASTech Complete UV Filter Business Cooperation MOU and Investment Closing, Accelerating Global Market Expansion